Summary
In recent years transcranial sonography (TCS) has become a widely used method for the visualization of the brain parenchyma through the intact scull. Using TCS, our group discovered changes of the echotexture — namely increased echogenicity — at the substantia nigra (SN) in about 90% of patients with Parkinson’s disease (PD). These results assessed with an interrater reproducibility of r=0.8 in several studies have been confirmed by several other groups. In contrast increased SN echogenicity is rarely found in patients with atypical or symptomatic Parkinsonian syndromes, providing a valuable tool for differential diagnosis.
Interestingly, increased SN echogenicity can also be found in about 8 to 10% of healthy subjects. In PET analyses more than 60% of these clinically healthy individuals show a subclinical reduction of the striatal 18F-Dopa uptake indicating an alteration of the dopaminergic nigrostriatal system and nigral cell loss. Furthermore, it was possible to demonstrate that this ultrasound finding has a functional impact as subjects with an increased echogenicity of the SN (i) showed more frequently clinical symptoms of asymmetric hypokinesia with increasing age and (ii) developed more often and more severe Parkinsonian side effects when treated with neuroleptic therapy for neuropsychiatric disorders. Longitudinal studies indicate that the ultrasound signal does not change in the course of the disease. Moreover, presymptomatic carriers of mutations causative for monogenetic PD display the same echofeature as their relatives already affected by the disease. These findings indicate that increased SN echogenicity constitutes a biomarker for vulnerability of the nigrostriatal system in healthy subjects and eventually PD in a subgroup of persons with additional risk factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography. Neurology 45: 443–454
Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson’s disease and atypical Parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76: 423–425
Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53: 1026–1031
Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G (2001a) Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50: 463–467
Berg D, Merz B, Reiners K, Naumann M, Becker G (2005) A five year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease. Mov Disord 20: 383–385
Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra — association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59: 999–1005
Berg D, Siefker C, Becker G (2001b) Echogenicity of the substantia nigra in Parkinson’s disease and its relation to clinical findings. J Neurol 248: 684–689
Berg D, Siefker C, Ruprecht-Dorfler P, Becker G (2001c) Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56: 13–17
Niehaus L, Savyer N, Weber U, Hertel R, Trottenberg T, Kupsch A (2004) Brain parenchyma sonography in patients with essential tremor and Parkinson’s disease. Cerebrovasc Dis 17[Suppl 4]: 3
Ruprecht-Dorfler P, Berg D, Tucha O, Benz P, Meier-Meitinger M, Alders GL, Lange KW, Becker G (2003) Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson’s disease. Neuroimage 18: 416–422
Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R (2004a) Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63: 504–509
Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D (2004b) Brain parenchyma sonography detects preclinical parkinsonism. MovDisord 19: 1445–1449
Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D (2003) Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes. Neurology 60: 74–77
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag
About this paper
Cite this paper
Berg, D. (2006). Transcranial sonography in the early and differential diagnosis of Parkinson’s disease. In: Riederer, P., Reichmann, H., Youdim, M.B.H., Gerlach, M. (eds) Parkinson’s Disease and Related Disorders. Journal of Neural Transmission. Supplementa, vol 70. Springer, Vienna . https://doi.org/10.1007/978-3-211-45295-0_38
Download citation
DOI: https://doi.org/10.1007/978-3-211-45295-0_38
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-28927-3
Online ISBN: 978-3-211-45295-0
eBook Packages: MedicineMedicine (R0)